Weight change trajectory in women with breast cancer receiving chemotherapy and the effect of different regimens.

CONCLUSION: The trajectory of body weight change within two years after chemotherapy shows a trend of gradual ascent, followed by a small decline and a slight increase in the last 2·5 months. The chemotherapy regimen can predict the trend after controlling for other confounders; women on cyclophosphamide, methotrexate and fluorouracil have a steeper weight change.
RELEVANCE TO CLINICAL PRACTICE: Nurses can inform women with breast cancer about the expected changes in body weight after chemotherapy to reduce their uncertainty. Future studies on effective interventions to minimise chemotherapy-induced weight gain are needed.
PMID: 24393441 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - January 7, 2014 Category: Cancer & Oncology Authors: Liu LN, Wen FH, Miaskowski C, Lin YC, Wang JS, Jeng C, Chen ML Tags: J Clin Nurs Source Type: research